Melanoma Clinical Trials in Florida

Showing 201-220 of 222 trials

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

NCT00671918

Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) for Navidea's Lymphoseek for use in intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.

Breast CancerMelanoma

Navidea Biopharmaceuticals186 participantsStarted Apr 2008

Alexander City, Alabama, United States • Birmingham, Alabama, United States • La Jolla, California, United States +12 more locations

COMPLETEDPhase 1/249 miles

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

NCT00005615

RATIONALE: Interferon alfa may interfere with the growth of tumor cells. Radiation therapy uses high-energy x-rays to damage tumor cells. Combining interferon alfa plus radiation therapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of interferon alfa plus radiation therapy in treating patients who have stage III or recurrent melanoma that has been removed by surgery.

Melanoma (Skin)

H. Lee Moffitt Cancer Center and Research Institute24 participantsStarted Jul 1997

Miami, Florida, United States • Tampa, Florida, United States

PreviousPage 11 of 12Next

Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Melanoma Trials in Other Cities

Sun Protection for Florida's Children

CP-675,206 In Patients With Advanced Melanoma

Combination of Anti-CD137 & Ipilimumab in Patients With Melanoma

Study of XL281 in Adults With Solid Tumors

A Phase I/II Study of Sunitinib and Dacarbazine

Safety and Immune Response to a Multi-component Immune Based Therapy (MKC1106-PP) for Patients With Advanced Cancer.

Chemotherapy With or Without Immunotherapy in Treating Patients With Stage III or Stage IV Melanoma

Study of CP-675,206 in Refractory Melanoma

Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma

Safety, Immune and Tumor Response to a Multi-component Immune Based Therapy (MKC1106-MT) for Patients With Melanoma

CP-675,206 Versus Either Dacarbazine Or Temozolomide In Patients Without Prior Therapy

In Vivo Confocal Microscopy for Pigmented Lesion Diagnosis

Evaluation of Pigmented Skin Lesions With MelaFind(R) System

Long-term Data Collection for Subjects in MDX-010 Studies

Temozolomide Plus Bevacizumab in Patients With Metastatic Melanoma Involving the Central Nervous System

Interferon Alfa and Thalidomide in Treating Patients With Stage IV Melanoma

S9804: Vinorelbine in Treating Patients With Stage IV Melanoma

Trial of Dacarbazine With or Without Genasense in Advanced Melanoma

Other Conditions in Florida